Leerink Partners Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform

Go back to Leerink Partners Upgrades ARS Pharmaceuticals Inc (SPRY) to Outperform
(NASDAQ: SPRY) Delayed: 3.38 -0.28 (7.65%)
Previous Close $3.66    52 Week High $ 
Open $3.62    52 Week Low $ 
Day High $3.79    P/E N/A 
Day Low $3.34    EPS $ 
Volume 1,756,764